Managing type 1 diabetes has a substantial impact on quality of life and psychological health. Indeed, insulin overdosing can ...

A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...

One Health is multi-species health”, Andrea Winkler tells me. “It is about the added value of joint agenda setting when it comes to the consideration of human health, animal health, and health of ...

Since its introduction in 2015, the global action plan (GAP) on antimicrobial resistance (AMR) has guided the global response to AMR1 and the development of 178 national action plans (NAPs). However, ...

John Amuasi is Head of the Global Health Department of the School of Public Health at the Kwame Nkrumah University of Science and Technology (KNUST) in Kumasi, Ghana, and Professor of Global One ...

Earth system scientists developed the planetary boundaries framework for measuring and tracking the stability and resilience ...

We appreciate the opportunity to address the comments by Yangfan Cheng and colleagues, and Sebastian Walsh and colleagues regarding our Article on long-term gantenerumab treatment in dominantly ...

In patients who had a stroke, high intensities of gait training are associated with improved walking capacity in terms of longer distances and faster speeds.1,2 However, there are few studies ...

The iconic superhero saving the planet, a warrior for good overcoming evil, the Man of Steel who paraded as geeky, ...

Seizure classification is vital for the management of people with seizures and epilepsy, as the type of seizure can determine therapeutic options. Specific seizure types often respond best to targeted ...

A plethora of treatments are available for the symptomatic management of Parkinson's disease. However, patients still have substantial unmet needs mostly due to fluctuating treatment effectiveness and ...

We read with great interest the Article by Randall J Bateman and colleagues investigating long-term gantenerumab treatment in dominantly inherited Alzheimer's disease.1 This important work provides ...